• CDC News
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Weight Management
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Kidney Disease
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

Umbilical Keloid

News
Article

A 3-month-old female infant presented with a mass in the umbilical area. During the neonatal period, an infection of the umbilical cord had resulted in the formation of exuberant granulation tissue at the base of the umbilicus.

A 3-month-old female infant presented with a mass in the umbilical area. During the neonatal period, an infection of the umbilical cord had resulted in the formation of exuberant granulation tissue at the base of the umbilicus. The granuloma pyogenicum so formed was cauterized with silver nitrate on several occasions. This resulted in the keloid seen here.

A sharply demarcated, benign, dense growth of connective tissue in the dermis, a keloid consists histologically of whorled and interlaced hyalinized collagen fibers. Keloids are usually induced by trauma and commonly follow ear piercing, surgical procedures, burns, and scalds. They are most common in dark-skinned persons.

Keloids should be differentiated from hypertrophic scars, which remain confined to the site of injury and gradually involute over time. In contrast, keloids usually outgrow the boundaries of the original insult; they also are more often pedunculated.

Keloids may be effectively treated with intralesional corticosteroids. Large lesions may require surgical excision followed by intralesional corticosteroid.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
© 2025 MJH Life Sciences

All rights reserved.